| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 1Q2QT5M7EO |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Programmed cell death protein 1 antagonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Uterine Cervical Neoplasms | 3 | D002583 | ClinicalTrials |
| Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
| Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Carcinoma, Pancreatic Ductal | 2 | D021441 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Papillomavirus Infections | 2 | D030361 | ClinicalTrials |
| Oropharyngeal Neoplasms | 2 | D009959 | ClinicalTrials |
| Diffuse Intrinsic Pontine Glioma | 1 | D000080443 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
| Endometrial Neoplasms | 1 | D016889 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297877 |
| FDA SRS | 1Q2QT5M7EO |
CONTENTS